Navigation Links
ViroPharma Incorporated and Idis Partner to Facilitate International Access to Certain ViroPharma Therapeutics Through Named Patient Program
Date:12/6/2010

EXTON, Pa. and WEYBRIDGE, England, Dec. 6, 2010 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) and Idis, the global leader in developing long-term strategic solutions to therapeutic access, today announced that the two companies have partnered to facilitate access to certain ViroPharma products through a named patient program (NPP).  ViroPharma's NPP, developed and managed by Idis, will allow international healthcare professionals to prescribe certain products to individual patients until the time that approval is sought in local countries.

Under an NPP, physicians can prescribe investigational or pre-approval products to qualifying patients on an individual basis. Such products can be administered to individual patients who are suffering from serious illnesses and have no other therapeutic options.  Idis will manage the ViroPharma NPP in countries, except the United States, where the products are not yet approved.

Licensed healthcare professionals in countries other than the United States where such ViroPharma products are not yet approved, can access the program at http://www.viropharmaNPP.com and on the physician section of the ViroPharma Incorporated corporate website (http://www.viropharma.com), or can contact Idis directly via telephone at +44(01)1952 824 100, fax +44 (0)1932 824 300, or via email at customerservices@idispharma.com.

"This program was developed for certain patients who have no alternative therapeutic option for their serious diseases," commented Thierry Darcis M.D., vice president, general manager, ViroPharma Europe. "They are in great need of access to investigational therapeutics that have either been approved in other parts of the world or have shown promise in clinical stu
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ViroPharma to Present at Three September Healthcare Conferences
2. ViroPharma to Present at Three October Healthcare Conferences
3. ViroPharma to Release 2008 Third Quarter Financial Results on October 29, 2008
4. ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
5. ViroPharma to Present at Three November Healthcare Conferences
6. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results
7. ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes
8. ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009
9. ViroPharma Incorporated Reports First Quarter 2009 Financial Results
10. ViroPharma Incorporated Honored by the National Organization for Rare Disorders
11. ViroPharma to Present at Two June Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... COSTA MESA, Calif. , July 24, 2014 /PRNewswire/ ... incredibly close to home. Rehealth Regenerative Therapies , ... offering athletes and other physically active people a new ... . Regardless of age, countless patients suffer ... amateur sport activities, such as muscle tears, torn rotator ...
(Date:7/24/2014)... yet to materialise. Yet, scientists are making progress ... faster. One such approach relies on quantum dotsa ... an electric field. A new study demonstrates that ... dots (TQDs) with electrical impulses can help better ... TQDs be used as quantum information units, which ...
(Date:7/24/2014)... 24, 2014 Your cell phone ... modeling lithium-ion battery storage capacity. , New research ... theoretical model created at Lawrence Livermore National ... predicts how carbon components will perform as electrodes. ... the urgent need for higher-performance batteries. Several key ...
(Date:7/24/2014)... , July 24, 2014  Neogen Corporation (Nasdaq: ... future forecasts of its potential revenue from new rodenticide ... to investors and analysts on July 22, 2014, Neogen,s ... analysts regarding this research. "It was my ... about the potential of a new type of rodenticide, ...
Breaking Biology Technology:Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3Getting More Life out of Lithium-ion Batteries 2Neogen comments on SenesTech 2
... Md., July 23 SuperArray,Bioscience Corporation announced today ... moved to a brand new facility three times,larger ... its phenomenal,growth over the last few years and ... expression analysis., "We are not just a ...
... amount of retraction needed for surgical ... ... Technology,today announces the market availability of the SlimFuse(TM) Anterior,Cervical Plate System. ... addressing the clinical needs of,anterior cervical discectomy and fusion (ACDF) surgery., ...
... Del., July 23 More than a third,of ... ) to inquire about the,company,s prescription savings programs ... according to a year-long survey of more than ... of the patients who called,AstraZeneca,s information center regarding ...
Cached Biology Technology:SuperArray Bioscience Changes Name to SABiosciences and Moves Into New Larger Facility on Verge of Tenth Anniversary 2Pioneer(R) Surgical Technology, Inc. Announces the Market Launch of the SlimFuse(TM) Anterior Cervical Plate System 2AstraZeneca Survey: Healthcare Professionals Leading Source of Information on Company's Prescription Savings Programs 2AstraZeneca Survey: Healthcare Professionals Leading Source of Information on Company's Prescription Savings Programs 3
(Date:7/24/2014)... July 24, 2014 /PRNewswire-iReach/ -- The Geneva Healthcare Suite, ... devices, has cut emergency room wait times by an ... (UCSD) Medical Center, according to a recent study published ... Departments are using the suite to access data from ... defibrillators. "Using Geneva,s technology platform we have ...
(Date:7/24/2014)... Invertebrate numbers have decreased by 45% on average over ... doubled, reports a study on the impact of humans ... the enormous benefits invertebrates such as insects, spiders, crustaceans, ... pollination and pest control for crops, decomposition for nutrient ... published in Science and led by UCL, ...
(Date:7/24/2014)... Los Angeles, where electric cars ply silent freeways, solar ... from beneath the earth, from howling winds and from ... finds that it is technically and economically feasible to ... clean, renewable energy. Published in Energy , the ... reliable energy supply in California that could create tens ...
Breaking Biology News(10 mins):UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 2UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 3Invertebrate numbers nearly halve as human population doubles 2Invertebrate numbers nearly halve as human population doubles 3Stanford study shows how to power California with wind, water and sun 2Stanford study shows how to power California with wind, water and sun 3Stanford study shows how to power California with wind, water and sun 4
... NY) -- Three researchers at the Albert Einstein College ... Cancer Research Foundation (BCRF). Drs. Thomas Rohan, Susan Horwitz ... in its ongoing effort to support the advancement of ... generosity is its mission, which is to achieve prevention ...
... a Green Revolution in Africa, a renowned group of ... Africa through agricultural productivity. They will cover sustainable agriculture, ... the symposium, The African Green Revolution Takes Shape, on ... room R02 of the Ernest N. Morial Convention Center ...
... Microbes such as bacteria tend to live in complex ... cause more problems for the immune system. Biofilms comprising ... serious chronic infectious diseases such as cystic fibrosis and ... biocorrosion. Yet biofilms also have equal potential ...
Cached Biology News:Einstein researchers receive grants totaling $700,000 for innovative breast cancer research 2Now is Africa's turn for a green revolution, global experts say 2Microbial biofilms evoke Jekyll & Hyde effects 2Microbial biofilms evoke Jekyll & Hyde effects 3
...
Request Info...
Streptomycin sulfate an aminoglycoside used for bacterial selection binds to the small ribosomal subunit and interferes with protein biosynthesis.21H39N7O12)2x3H2SO4Formula weight:...
Adducin beta (C-16)...
Biology Products: